464 related articles for article (PubMed ID: 17875567)
21. Differences in responses upon corticosteroid therapy between smoking and non-smoking patients with COPD.
Van Overveld FJ; Demkow U; Górecka D; De Backer WA; Zieliński J
J Physiol Pharmacol; 2006 Sep; 57 Suppl 4():273-82. PubMed ID: 17072055
[TBL] [Abstract][Full Text] [Related]
22. Bronchial inflammation and airway responses to deep inspiration in asthma and chronic obstructive pulmonary disease.
Slats AM; Janssen K; van Schadewijk A; van der Plas DT; Schot R; van den Aardweg JG; de Jongste JC; Hiemstra PS; Mauad T; Rabe KF; Sterk PJ
Am J Respir Crit Care Med; 2007 Jul; 176(2):121-8. PubMed ID: 17379851
[TBL] [Abstract][Full Text] [Related]
23. Evidence of angiogenesis in bronchial biopsies of smokers with and without airway obstruction.
Calabrese C; Bocchino V; Vatrella A; Marzo C; Guarino C; Mascitti S; Tranfa CM; Cazzola M; Micheli P; Caputi M; Marsico SA
Respir Med; 2006 Aug; 100(8):1415-22. PubMed ID: 16497496
[TBL] [Abstract][Full Text] [Related]
24. Current smoking-specific gene expression signature in normal bronchial epithelium is enhanced in squamous cell lung cancer.
Boelens MC; van den Berg A; Fehrmann RS; Geerlings M; de Jong WK; te Meerman GJ; Sietsma H; Timens W; Postma DS; Groen HJ
J Pathol; 2009 Jun; 218(2):182-91. PubMed ID: 19334046
[TBL] [Abstract][Full Text] [Related]
25. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers.
Makris D; Moschandreas J; Damianaki A; Ntaoukakis E; Siafakas NM; Milic Emili J; Tzanakis N
Respir Med; 2007 Jun; 101(6):1305-12. PubMed ID: 17112715
[TBL] [Abstract][Full Text] [Related]
26. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
Kömüs N; Tertemiz KC; Sevinç C
Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
[TBL] [Abstract][Full Text] [Related]
27. Decreased cytokine and chemokine mRNA expression in bronchoalveolar lavage in asymptomatic smoking subjects.
Meuronen A; Majuri ML; Alenius H; Mäntylä T; Wolff H; Piirilä P; Laitinen A
Respiration; 2008; 75(4):450-8. PubMed ID: 18230951
[TBL] [Abstract][Full Text] [Related]
28. [The relationship between bronchial hyperresponsiveness and chronic obstructive pulmonary disease].
Li Q; Xie G; Cheng X
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Oct; 24(10):584-7. PubMed ID: 11770417
[TBL] [Abstract][Full Text] [Related]
29. Expression of epidermal growth factors and their receptors in the bronchial epithelium of subjects with chronic obstructive pulmonary disease.
de Boer WI; Hau CM; van Schadewijk A; Stolk J; van Krieken JH; Hiemstra PS
Am J Clin Pathol; 2006 Feb; 125(2):184-92. PubMed ID: 16393673
[TBL] [Abstract][Full Text] [Related]
30. Quantitative differentiation of dendritic cells in lung tissues of smokers with and without chronic obstructive pulmonary disease.
Su YW; Xu YJ; Liu XS
Chin Med J (Engl); 2010 Jun; 123(12):1500-4. PubMed ID: 20819500
[TBL] [Abstract][Full Text] [Related]
31. Bronchial vascular remodelling in patients with COPD and its relationship with inhaled steroid treatment.
Zanini A; Chetta A; Saetta M; Baraldo S; Castagnetti C; Nicolini G; Neri M; Olivieri D
Thorax; 2009 Dec; 64(12):1019-24. PubMed ID: 19736178
[TBL] [Abstract][Full Text] [Related]
32. Systemic CD4+ T-cell activation is correlated with FEV1 in smokers.
Glader P; von Wachenfeldt K; Löfdahl CG
Respir Med; 2006 Jun; 100(6):1088-93. PubMed ID: 16246539
[TBL] [Abstract][Full Text] [Related]
33. [Airway inflammation and lymphocyte subset analysis in patients with chronic obstructive pulmonary disease and healthy smokers].
Yurdakul AS; Taci Hoca N; Cimen F; Atikcan S; Sipit T; Atasever M; Balci M
Tuberk Toraks; 2006; 54(2):122-7. PubMed ID: 16924567
[TBL] [Abstract][Full Text] [Related]
34. Peripheral arterial disease: an underestimated aetiology of exercise intolerance in chronic obstructive pulmonary disease patients.
Castagna O; Boussuges A; Nussbaum E; Marqueste L; Brisswalter J
Eur J Cardiovasc Prev Rehabil; 2008 Jun; 15(3):270-7. PubMed ID: 18446087
[TBL] [Abstract][Full Text] [Related]
35. The occurrence of chronic obstructive pulmonary disease (COPD) in cigarette smoking families.
Kałucka S
Przegl Lek; 2006; 63(10):848-57. PubMed ID: 17288170
[TBL] [Abstract][Full Text] [Related]
36. Expression of vascular remodelling markers in relation to bradykinin receptors in asthma and COPD.
Ricciardolo FL; Sabatini F; Sorbello V; Benedetto S; Defilippi I; Petecchia L; Usai C; Gnemmi I; Balbi B; De Rose V; Ten Hacken NH; Postma DS; Timens W; Di Stefano A
Thorax; 2013 Sep; 68(9):803-11. PubMed ID: 23739138
[TBL] [Abstract][Full Text] [Related]
37. Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD.
Di Stefano A; Caramori G; Gnemmi I; Contoli M; Bristot L; Capelli A; Ricciardolo FL; Magno F; D'Anna SE; Zanini A; Carbone M; Sabatini F; Usai C; Brun P; Chung KF; Barnes PJ; Papi A; Adcock IM; Balbi B
Thorax; 2009 Nov; 64(11):968-75. PubMed ID: 19703829
[TBL] [Abstract][Full Text] [Related]
38. CD8(+) T cells characterize early smoking-related airway pathology in patients with asthma.
Ravensberg AJ; Slats AM; van Wetering S; Janssen K; van Wijngaarden S; de Jeu R; Rabe KF; Sterk PJ; Hiemstra PS
Respir Med; 2013 Jul; 107(7):959-66. PubMed ID: 23639272
[TBL] [Abstract][Full Text] [Related]
39. Chemotactic mediators of Th1 T-cell trafficking in smokers and COPD patients.
Brozyna S; Ahern J; Hodge G; Nairn J; Holmes M; Reynolds PN; Hodge S
COPD; 2009 Feb; 6(1):4-16. PubMed ID: 19229703
[TBL] [Abstract][Full Text] [Related]
40. Better understanding the influence of cigarette smoking and indoor air pollution on chronic obstructive pulmonary disease: a case-control study in Mainland China.
Xu F; Yin X; Shen H; Xu Y; Ware RS; Owen N
Respirology; 2007 Nov; 12(6):891-7. PubMed ID: 17986120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
